Search research articles
Contact Us
Filters
Showing results (11-20 of 87) with videos related to
Page
of 9
Sort By:
The New England Journal of Medicine
|
June 23, 2006
Cyclophosphamide for scleroderma lung disease
Fernando J Martinez, W Joseph McCune
The Journal of Rheumatology
|
June 9, 2005
Mycophenolate mofetil: a magic bullet for lupus?
W Joseph McCune, Mona M Riskalla
Lancet (London, England)
|
April 4, 2003
New evidence for vascular disease in patients with early rheumatoid arthritis
Mariana J Kaplan, W Joseph McCune
Current Opinion in Rheumatology
|
March 19, 2015
Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?
W Joseph McCune, Tania Gonzalez-Rivera
Current Opinion in Rheumatology
|
March 31, 2016
Suppression of normal immune responses after treatment with rituximab
Ruba Kado, Georgiana Sanders, W Joseph McCune
Current Opinion in Rheumatology
|
February 28, 2017
Diagnostic and therapeutic considerations in patients with hypogammaglobulinemia after rituximab therapy
Ruba Kado, Georgiana Sanders, W Joseph McCune
American Journal of Respiratory and Critical Care Medicine
|
November 7, 2007
Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?
Athol U Wells, Panagiota Latsi, W Joseph McCune
BMJ Case Reports
|
July 27, 2019
West Nile encephalitis mimicking neuropsychiatric lupus in a patient with systemic lupus erythematosus
Neena R Iyer, W Joseph McCune, Beth I Wallace
Current Opinion in Rheumatology
|
March 2, 2016
Treatment of catastrophic antiphospholipid syndrome
Nayef M Kazzaz, W Joseph McCune, Jason S Knight
Current Opinion in Rheumatology
|
March 20, 2021
The use of mycophenolate mofetil area under the curve
Katherine Chakrabarti, David Frame, Mousa Al Abbas, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 87) with videos related to
Sort By:
Page
of 9
The New England Journal of Medicine
|
June 23, 2006
Cyclophosphamide for scleroderma lung disease
Fernando J Martinez, W Joseph McCune
The Journal of Rheumatology
|
June 9, 2005
Mycophenolate mofetil: a magic bullet for lupus?
W Joseph McCune, Mona M Riskalla
Lancet (London, England)
|
April 4, 2003
New evidence for vascular disease in patients with early rheumatoid arthritis
Mariana J Kaplan, W Joseph McCune
Current Opinion in Rheumatology
|
March 19, 2015
Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?
W Joseph McCune, Tania Gonzalez-Rivera
Current Opinion in Rheumatology
|
March 31, 2016
Suppression of normal immune responses after treatment with rituximab
Ruba Kado, Georgiana Sanders, W Joseph McCune
Current Opinion in Rheumatology
|
February 28, 2017
Diagnostic and therapeutic considerations in patients with hypogammaglobulinemia after rituximab therapy
Ruba Kado, Georgiana Sanders, W Joseph McCune
American Journal of Respiratory and Critical Care Medicine
|
November 7, 2007
Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?
Athol U Wells, Panagiota Latsi, W Joseph McCune
BMJ Case Reports
|
July 27, 2019
West Nile encephalitis mimicking neuropsychiatric lupus in a patient with systemic lupus erythematosus
Neena R Iyer, W Joseph McCune, Beth I Wallace
Current Opinion in Rheumatology
|
March 2, 2016
Treatment of catastrophic antiphospholipid syndrome
Nayef M Kazzaz, W Joseph McCune, Jason S Knight
Current Opinion in Rheumatology
|
March 20, 2021
The use of mycophenolate mofetil area under the curve
Katherine Chakrabarti, David Frame, Mousa Al Abbas, et al.
Page
of 9